β οΈ If overdose β potentially lethal myelosuppression.
π Dose for rheumatic disease is 10β25 mg once per week.
β If given daily by accident, the patient may die.
π Advise to seek medical help urgently if any fever, sore throat, bruising, or mouth ulcers.
π Methotrexate toxicity β consider Folinic acid 15 mg IV OD.
- π Cytotoxic agent and DMARD.
- β οΈ Potentially lethal if taken or prescribed daily or dosed wrongly.
Actions
- π¬ Structural analogue of folate.
- β Inhibits dihydrofolic acid reductase β blocks DNA synthesis.
- π§© DMARD effect mechanism unclear.
- π‘οΈ Folinic acid reverses effects of methotrexate.
Indications
- π€² Rheumatoid arthritis (DMARD, onset 4β6 wks).
- ποΈ Cancer chemotherapy (ALL, NHL, choriocarcinoma, Burkittβs lymphoma, cutaneous T-cell lymphoma).
- π§΄ Severe psoriasis.
- π€° Ectopic pregnancy (specialist use).
Dose
- π Rheumatoid disease: Start 7.5 mg once weekly, β by 2.5 mg every 6 wks to 15β25 mg once weekly.
β Give folic acid 5 mg the day after MTX. Reduce dose in elderly/renal impairment.
- ποΈ Oncology: Daily high-dose regimens, specialist use only.
- π€° Ectopic pregnancy: Single IM dose 50 mg/mΒ² or 1 mg/kg (β 75β100 mg). Follow local protocols.
Dose Range (non-oncology weekly regimens)
| Name | Dose | Frequency | Route |
| Methotrexate (Rheumatoid disease) | 7.5β25 mg | Weekly | PO |
| Methotrexate (Severe Crohnβs disease) | 10β25 mg | Weekly | PO |
| Methotrexate (Severe Psoriasis) | 2.5β25 mg | Weekly | PO |
Interactions
- β Acitretin β β MTX toxicity.
- β NSAIDs/Aspirin/Probenecid β β MTX toxicity.
- β Ciclosporin β β MTX toxicity.
Cautions
- π§ Effusions (ascites, pleural) β drain before MTX or risk toxicity.
- π· Avoid hepatotoxic drugs, alcohol, porphyria.
- π©βπΌ Women must use contraception during and 3 months after MTX.
Contraindications
- π« eGFR <30 mL/min.
- π« Active infection (shingles, HSV, bacterial, varicella).
- π« Pregnancy, breastfeeding, large effusion, liver/renal dysfunction.
- π« Immunodeficiency, bone marrow failure (anaemia, leukopenia, thrombocytopenia).
- π« Alcoholism, chronic liver disease.
Side Effects
- π€’ GI upset: nausea, vomiting, anorexia.
- π©Έ Haematological: bone marrow suppression, cytopenias.
- π· Hypersensitivity pneumonitis (2β5%, reversible).
- π¦ Opportunistic infections (e.g. Pneumocystis jirovecii).
- π§ββοΈ Hepatic: transaminase rise, fibrosis, cirrhosis with long-term use.
- π Oral ulcers (reduced with folate 5 mg).
- π Hair loss, stomatitis, diarrhoea, tumour lysis syndrome.
Toxicity
- Folic acid (given on non-MTX days) reduces toxicity.
- π¨ Severe MTX toxicity β Folinic acid 15 mg IV OD.